News
The future of mass student debt cancellation remains in limbo after the Supreme Court struck down President Joe Biden’s initial debt relief plan last...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Knox Ridley began consulting on portfolios in 2007 and is an experienced growth investor in both bull and...
News
This article was written by Follow Richard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the...
News
This article was written by Follow Raymond James Investment Management is a global asset management company that combines the exceptional insight and agility of...
News
It was once believed that rap and hip-hop would be a passing fad, yet those genres along with R&B have dominated the last decade...
News
Adyen (OTCPK:ADYEY) is one of my highest conviction name and I have done a deep dive into the name for members of Outperforming the...
News
This article series aims at evaluating ETFs (exchange-traded funds) regarding past performance and portfolio metrics. Reviews with updated data are posted when necessary. DOL...
News
If top investment banks, consulting and law firms care about a diverse entry-level recruiting pool, they’re going to have to develop a wider pipeline....
News
Introduction The priority of shareholders is held high within Artisan Partners Asset Management (NYSE:APAM). The company distributes a majority of all the cash flows...
News
Self-storage REITs have been gaining popularity due to the industry’s rapid growth over the last three years. Although 75% of the industry comprises small...
News
If you’re considering a new car, you’ve probably found all the hype about electric vehicles difficult to ignore. Today, we aren’t addressing the pros...
News
Oakmark Select Fund (MUTF:OAKLX) – Investor ClassAverage Annual Total Returns 03/31/23Since Inception 11/01/96 11.08%10-year 8.69%5-year 4.89%1-year -8.77%3-month 10.91% Expense Ratio: 0.98% Expense ratios are...
News
Introduction Prime Medicine (NASDAQ:PRME) is a biotech firm pioneering the use of Prime Editors, revolutionary genetic therapies that offer precise, efficient and broad gene...
